sch 23982 has been researched along with papaverine in 1 studies
Studies (sch 23982) | Trials (sch 23982) | Recent Studies (post-2010) (sch 23982) | Studies (papaverine) | Trials (papaverine) | Recent Studies (post-2010) (papaverine) |
---|---|---|---|---|---|
87 | 0 | 0 | 6,027 | 305 | 355 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackerman, M; Artman, LD; Asin, KE; Bednarz, L; Johnson, MC; Kebabian, JW; Kerkman, DJ; MacKenzie, RG; Montana, W; Stampfli, H | 1 |
1 other study(ies) available for sch 23982 and papaverine
Article | Year |
---|---|
A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Benzazepines; Binding, Competitive; Catalepsy; Dihydroxyphenylalanine; Haloperidol; Injections, Subcutaneous; Iodine Radioisotopes; Male; Motor Activity; Papaverine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Tetrahydroisoquinolines | 1989 |